HEICO Corporation (NYSE:HEI) shares increased 2.23% in last trading session and ended the day at $50.52. HEI Gross Margin is 35.60% and its has a return on assets of 8.20%. HEICO Corporation (NYSE:HEI) quarterly performance is -8.25%.
HEICO Corporation (NYSE:HEI) was upgraded by Zacks from a “sell” rating to a “hold” rating in a note issued to investors on Monday, Analyst Ratings Network.com reports.
PNM Resources, Inc. (NYSE:PNM) ended the last trading day at $28.14. Company weekly volatility is calculated as 2.28% and price to cash ratio as 83.32. PNM Resources, Inc. (NYSE:PNM) showed a weekly performance of 3.00%.
On 9 November, PNM Resources, Inc. (NYSE:PNM) issued a request for proposal (RFP) for the engineering, procurement and construction of a natural gas combustion turbine generator(s) and related equipment on a build-own-transfer (turnkey) basis.
On 16 November, China Ceramics Co., Ltd. (NASDAQ:CCCL) shares increased 0.01% and was closed at $0.96. CCCL EPS growth in last 5 year was -15.60%. China Ceramics Co., Ltd. (NASDAQ:CCCL) year to date (YTD) performance is 18.52%.
China Ceramics Co., Ltd. (NASDAQ:CCCL) announced it will conduct a conference call at 8:00 am Eastern Timeon Thursday, November 19, 2015to discuss its financial results for the third quarter ended September 30, 2015.
Basic Energy Services, Inc. (NYSE:BAS) shares increased 5.26% in last trading session and ended the day at $3.80. BAS Gross Margin is 25.50% and its has a return on assets of -14.30%. Basic Energy Services, Inc. (NYSE:BAS) quarterly performance is -21.81%.
On 11 November, Basic Energy Services, Inc. (NYSE:BAS) reported selected operating data for the month of October 2015. Basic’s well servicing rig count remained unchanged at 421. Well servicing rig hours for the month were 44,400 producing a rig utilization rate of 44%, compared to 46% and 73% in September 2015 and October 2014, respectively.
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) caters to the Healthcare space. Its weekly performance is -9.09%. On the last day of trading company shares ended up at $59.13. Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) distance from 50-day simple moving average (SMA50) is 5.55%.
On 8 November, Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) announced the first data from the dose-escalation portion of the ongoing Phase 1 study evaluating single agent AG-120, a first-in-class, oral, selective, potent inhibitor of mutant isocitrate dehydrogenase-1 (IDH1), in advanced solid tumors. The data are being presented today at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston. AG-120 is being developed in collaboration with Celgene.
Leave a Reply